A detailed history of Cubist Systematic Strategies, LLC transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 22,825 shares of TLSA stock, worth $31,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,825
Holding current value
$31,726
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.63 - $1.69 $14,379 - $38,574
22,825 New
22,825 $24,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $0.82 $3,240 - $4,428
-5,401 Reduced 30.86%
12,099 $7,000
Q2 2023

Aug 14, 2023

BUY
$0.65 - $1.29 $11,375 - $22,575
17,500 New
17,500 $11,000

Others Institutions Holding TLSA

About Tiziana Life Sciences Ltd


  • Ticker TLSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,273,000
  • Market Cap $142M
  • Description
  • Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...
More about TLSA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.